跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rabeprazole Sandoz Gastro Resistant Tablet 20mg - HSA Drug Approval Details
Approvals
/
HSA
/
Rabeprazole Sandoz Gastro Resistant Tablet 20mg
Approved
THERAPEUTIC
Rabeprazole Sandoz Gastro Resistant Tablet 20mg
Lek Pharmaceuticals d.d.Lek Pharmaceuticals d.d. Lendava (Primary and Secondary Packager)
🇸🇬 Health Sciences Authority
Approval Date
Mar 8, 2013
Approval ID
2b167a7e26412bc9
Company
Lek Pharmaceuticals d.d.Lek Pharmaceuticals d.d. Lendava (Primary and Secondary Packager)
Type
Therapeutic
Approval Details
Approval Id
2b167a7e26412bc9
Drug Name
Rabeprazole Sandoz Gastro Resistant Tablet 20mg
Product Name
Rabeprazole Sandoz Gastro Resistant Tablet 20mg
Approval Number
SIN14319P
Approval Date
2013-03-08
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, ENTERIC COATED
Route Of Administration
ORAL
Atc Code
A02BC04
Atc Item Name
rabeprazole
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
Rabeprazole 18.85mg eqv Rabeprazole Sodium
20mg
Rabeprazole 18.85mg eqv Rabeprazole Sodium
20mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 8, 2013
Approval ID
2b167a7e26412bc9
Type
Therapeutic
Back to HSA Approvals
